JP2022504798A5 - - Google Patents
Info
- Publication number
- JP2022504798A5 JP2022504798A5 JP2021520179A JP2021520179A JP2022504798A5 JP 2022504798 A5 JP2022504798 A5 JP 2022504798A5 JP 2021520179 A JP2021520179 A JP 2021520179A JP 2021520179 A JP2021520179 A JP 2021520179A JP 2022504798 A5 JP2022504798 A5 JP 2022504798A5
- Authority
- JP
- Japan
- Prior art keywords
- zwitterion
- tautomer
- prodrug
- salt
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1816639.7A GB201816639D0 (en) | 2018-10-12 | 2018-10-12 | GLP-1 Receptor Antagonist |
| GB1816639.7 | 2018-10-12 | ||
| PCT/GB2019/052915 WO2020074927A2 (en) | 2018-10-12 | 2019-10-14 | Glp-1 receptor antagonists |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504798A JP2022504798A (ja) | 2022-01-13 |
| JP2022504798A5 true JP2022504798A5 (https=) | 2022-10-24 |
| JP7492507B2 JP7492507B2 (ja) | 2024-05-29 |
Family
ID=64397527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021520179A Active JP7492507B2 (ja) | 2018-10-12 | 2019-10-14 | Ｇｌｐ－１受容体アンタゴニスト |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12441777B2 (https=) |
| EP (1) | EP3863661A2 (https=) |
| JP (1) | JP7492507B2 (https=) |
| CN (1) | CN113166206A (https=) |
| AU (1) | AU2019358324B2 (https=) |
| CA (1) | CA3115448A1 (https=) |
| GB (1) | GB201816639D0 (https=) |
| WO (1) | WO2020074927A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202011604D0 (en) * | 2020-07-27 | 2020-09-09 | Heptares Therapeutics Ltd | GLP-1 receptor antagonists |
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7399489B2 (en) | 1999-01-14 | 2008-07-15 | Amylin Pharmaceuticals, Inc. | Exendin analog formulations |
| CN100540565C (zh) | 2005-01-14 | 2009-09-16 | 无锡宏创医药科技有限公司 | 修饰的Exendins及其应用 |
| WO2007139941A2 (en) | 2006-05-26 | 2007-12-06 | Amylin Pharmaceuticals, Inc. | Composition and methods for treatment of congestive heart failure |
| WO2010032509A1 (ja) * | 2008-09-20 | 2010-03-25 | 国立大学法人京都大学 | 膵島イメージング用分子プローブ前駆体及びその使用 |
| WO2010120476A2 (en) | 2009-04-01 | 2010-10-21 | Amylin Pharmaceuticals, Inc. | N-terminus conformationally constrained glp-1 receptor agonist compounds |
| CN101870728A (zh) | 2009-04-23 | 2010-10-27 | 派格生物医药(苏州)有限公司 | 新型Exendin变体及其缀合物 |
| WO2011027584A1 (ja) * | 2009-09-04 | 2011-03-10 | 国立大学法人京都大学 | 膵島イメージング用分子プローブ及びその使用 |
| US9278146B2 (en) * | 2010-10-08 | 2016-03-08 | Kyoto University | Peptide derivative and use of the same |
| CN102532301B (zh) * | 2010-12-31 | 2014-09-03 | 上海医药工业研究院 | 一类新型的Exendin-4类似物及其制备方法 |
| GB201315335D0 (en) * | 2013-08-29 | 2013-10-09 | Of Singapore | Amino diacids containing peptide modifiers |
| LT3297653T (lt) * | 2015-05-22 | 2022-01-10 | The Board Of Trustees Of The Leland Stanford Junior University | Postbariatrinės hipoglikemijos gydymas glp-1 antagonistais |
-
2018
- 2018-10-12 GB GBGB1816639.7A patent/GB201816639D0/en not_active Ceased
-
2019
- 2019-10-14 US US17/284,351 patent/US12441777B2/en active Active
- 2019-10-14 JP JP2021520179A patent/JP7492507B2/ja active Active
- 2019-10-14 CN CN201980080295.9A patent/CN113166206A/zh active Pending
- 2019-10-14 EP EP19790753.8A patent/EP3863661A2/en active Pending
- 2019-10-14 WO PCT/GB2019/052915 patent/WO2020074927A2/en not_active Ceased
- 2019-10-14 CA CA3115448A patent/CA3115448A1/en active Pending
- 2019-10-14 AU AU2019358324A patent/AU2019358324B2/en active Active
-
2025
- 2025-06-26 US US19/251,101 patent/US20250368709A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6594487B2 (ja) | 抗ウイルス化合物の合成 | |
| JP2022504798A5 (https=) | ||
| JP7290638B2 (ja) | Ｗｅｅ１阻害剤としての大環状化合物及びその使用 | |
| JP5164181B2 (ja) | トロンボポエチン受容体アゴニスト作用を有する光学活性な化合物を含有する医薬組成物およびその中間体 | |
| CN107531646B (zh) | 尿嘧啶化合物的结晶 | |
| CZ20001613A3 (cs) | Způsob výroby oxazolidinonů | |
| US20220127259A1 (en) | Solid state forms of valbenazine | |
| CA2938280A1 (en) | 4-amino-imidazoquinoline compounds | |
| JPH07116181B2 (ja) | Ｎ―置換―４―ピリミジンアミンおよび―ピリミジンジアミン | |
| JP2003500404A5 (https=) | ||
| WO2011134284A1 (zh) | 胰高血糖素样肽-1类似物及其应用 | |
| JP2022535838A (ja) | ピロロピリミジン類化合物及びその使用 | |
| JP2023535476A5 (https=) | ||
| ES2770348T3 (es) | Forma cristalina del compuesto (s)-3-{4-[5-(2-ciclopentil-6-metoxi-piridin-4-il)-[1,2,4]oxadiazol-3-il]-2-etil-6-metil-fenoxi}-propano-1,2-diol | |
| ES2543199T3 (es) | Síntesis y usos de derivados del ácido piroglutámico | |
| JPH06501023A (ja) | 抗腫瘍活性を増強するためのピリミジン誘導体 | |
| WO2020057604A1 (zh) | Tlr8激动剂 | |
| US8592588B2 (en) | Process to prepare camptothecin derivatives | |
| WO2011065420A1 (ja) | ６－置換－１－メチル－１ｈ－ベンズイミダゾール誘導体の製造法及びその製造中間体 | |
| AU2020285269B2 (en) | Bicyclic compound as RIP-1 kinase inhibitor and application thereof | |
| AU746588B2 (en) | Stereoisomeric indole compounds, process for the preparation of the same, and use thereof | |
| WO2023011359A1 (zh) | 桥环类化合物及其应用 | |
| JP5871905B2 (ja) | グルカゴン様ペプチド−１類似体およびその使用 | |
| KR102398639B1 (ko) | 아미드 유도체의 염 및 그 제조방법 | |
| US20260015365A1 (en) | Prodrugs of somatostatin receptors subtype 4 (sstr4) agonists and their applications |